COPENHAGEN, Denmark, 11 January 2022 – BioInnovation Institute (BII), a non-for profit Foundation known for incubating and advancing world-class life science research, today announces the award of a grant from the Bill & Melinda Gates Foundation to accelerate efforts to discover translational world-class research to identify new technologies and solutions that can improve the health of women […]
First company to develop an AI product to predict egg viability with potential to significantly improve IVF outcomes Financing led by M Ventures with participation from Whitecap Venture Partners Toronto, Canada, January 6 2022 – Future Fertility, a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical decision making in fertility care and […]
Youth unemployment in Jordan is record high, and up to 50% of young people were out of work in 2020. With a grant from the Novo Nordisk Foundation of DKK 200 million, PlanBørnefonden will work purposefully to give more young people access to jobs and income opportunities. The Foundation has donated more than DKK 500 million to […]
Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces that it will be attending Biotech Showcase: The Investor Conference for Innovators on 10-12 January 2022. The Versameb team will be attending virtually. Read more…
ENHANCE-2 Screening Complete with Full Enrollment Expected in January 2022 ENHANCE Phase 3 Program on Track to Report Top-line Data in 2022 LONDON and RALEIGH, N.C., Jan. 05, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces enrollment completed in the […]
